STRAMADA
LIVE

Serial Number

79269415

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

STRAMADA Trademark

Serial Number: 79269415 • Registration: 6004756

STRAMADA is a trademark filed by NOVARTIS AG on August 21, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 21, 2019

Registration Date

March 10, 2020

Published for Opposition

December 24, 2019

Cancellation Date

January 13, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Aug 9, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Aug 9, 2022 DETH
NOTIFICATION PROCESSED BY IB
Jun 5, 2020 GPNX
NOTIFICATION PROCESSED BY IB
May 22, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 9, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 10, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 4, 2019 NONP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 22, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 22, 2019 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 15, 2019 CNSA
ASSIGNED TO EXAMINER
Nov 15, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 22, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 15, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 10, 2019 SDRC